PRISM MarketView

NeuroSense Therapeutics Initiates Regulatory Submission for Early Commercialization of ALS Treatment in Canada

New York, October 09, 2024 - PRISM MarketView - NeuroSense Therapeutics (NASDAQ: NRSN) has begun the regulatory process to seek early commercialization approval for its lead drug candidate, PrimeC, in Canada under Health Canada’s Notice of Compliance with Conditions (NOC...

9 October 2024

Counting Points Was So 90’s. Weight Watchers (WW) Soars Over 40% On Compounded GLP-1 Offering

New York, October 09, 2024 - PRISM MarketView - WeightWatchers (WW) announced it will be adding compounded semaglutide to is offering. This will enhance the company’s holistic weight management program and provide its members to access to behavioral and clinical solution...

9 October 2024

Aditxt (ADTX) and Evofem (EVFM) Continue Strides Toward Improving Women’s Health; Complete Third Parent Equity Investment Under Merger Agreement

New York, October 08, 2024 - PRISM MarketView - Aditxt, Inc. (ADTX), an innovative platform dedicated to accelerating health outcomes and Evofem Biosciences, Inc. (EVFM), women’s health focused company have announced the completion of the Third Parent Equity Investment u...

8 October 2024

Scholar Rock (SRRK) Shares Soar over 320% on SMA Topline Results from Phase 3 SAPPHIRE Trial

New York, October 07, 2024 - PRISM MarketView - The late-stage biopharmaceutical company Scholar Rock (SRRK) who focuses on treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases has provided topline results from its Phase 3 ...

7 October 2024

New Faces Driving AI: Cerence (CRNC) Has Appointed a New CEO and Reaffirms FY 2024 Guidance, Shares Up ~30%

New York, October 07, 2024 - PRISM MarketView - The PRISM NextGen Tech and AI Index company, Cerence Inc. (CRNC) who focuses on mobility and AI has announced the appointment of new CEO, Brian Krzanich who will succeed Stefan Ortmanns. Mr. Krzanich had previously been app...

7 October 2024

Global Marriott Hotel-Chain Developer, Lance Shaner Leads $11M Investment into SKYX Platforms (SKYX)

New York, October 07, 2024 - PRISM MarketView - Smart lighting technology platform SKYX Platforms Corp (SKYX) announced the completion of an $11M strategic investment of a new class of preferred stock in SKYX at a conversion price of $2.00 per common share with an 8% div...

7 October 2024

IONQ Marks Significant Milestone Advancing Ion-Ion Entanglement

New York, October 04, 2024 - PRISM MarketView - IonQ, (IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglement bre...

4 October 2024

If You Didn’t Think EVGO Could Get Any Greener, It Just Has. Shares Soar 60% on $1Bn DOE Loan

New York, October 03, 2024 - PRISM MarketView - PRISM Emerging EV Index company EVgo, Inc. (EVGO) has announced it received a conditional commitment loan guarantee from the US Department of Energy (DOE) for up to $1.05Bn of debt financing to accelerate its fast charging ...

3 October 2024

Aditxt (ADTX) Provides Shareholder Update and 2024 Year-End Plan

New York, October 03, 2024 - PRISM MarketView - Today Aditxt Inc. (ADTX) an innovation platform anchored in accelerating promising health innovations, provided a shareholder update and its 2024 year-end plan. In the report the company highlighted progress from both of it...

3 October 2024

Oncocyte Drives Investor Interest with Dual Announcements on Corporate Growth

New York, October 03, 2024 - PRISM MarketView - Oncocyte Corporation (Nasdaq: OCX), a diagnostics technology company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the care journey, is making headli...

3 October 2024